MIRA Pharmaceuticals Stock Target Price and Analyst Consensus
| MIRA Stock | 1.34 0.09 6.29% |
The current analyst and expert consensus on MIRA Pharmaceuticals is Hold, with no strong buy opinions. The current projected MIRA Pharmaceuticals target price consensus is 17.75 with 1 analyst opinions. Check out Macroaxis Advice on MIRA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way MIRA Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview MIRA Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on MIRA Pharmaceuticals. We encourage you to use your own analysis of MIRA Pharmaceuticals to validate this buy or sell advice. MIRA Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected MIRA Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.9231.
Lowest Forecast 16.15 | Highest Forecast 19.7 | Target Price 17.75 |
It's important to approach MIRA Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize MIRA Pharmaceuticals price targets
MIRA Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using MIRA Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at MIRA Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if MIRA Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional MIRA Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of MIRA Pharmaceuticals is a key component of MIRA Pharmaceuticals valuation and have some predictive power on the future returns of a MIRA Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 100 shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Momentum Invested over 30 shares | |
 | Investor Favorites Invested few shares | |
 | Dividend Beast Invested over 30 shares | |
 | Adviser Favorites Invested few shares |
Check out Macroaxis Advice on MIRA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Please note, the presentation of MIRA Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MIRA Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MIRA Pharmaceuticals' management manipulating its earnings.